Immunohistochemical Analysis of RTKs Expression Identified HER3 as a Prognostic Indicator of Gastric Cancer

Cancer Science - United States
doi 10.1111/cas.12556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

PLoS ONE
Multidisciplinary
2013English

Positive Prognostic Value of HER2-HER3 Co-Expression and P-mTOR in Gastric Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Correction: B7-H4 as an Independent Prognostic Indicator of Cancer Patients: A Meta-Analysis

Oncotarget
Oncology
2018English

Level of Topoisomerase IIα Expression as a Prognostic Indicator in Patients With Breast Cancer (Literature Review)

Practical oncology
2018English

Immunohistochemical Expression of ABCB5 as a Potential Prognostic Factor in Uveal Melanoma

Applied Sciences (Switzerland)
InstrumentationMaterials ScienceFluid FlowEngineeringComputer Science ApplicationsProcess ChemistryTransfer ProcessesTechnology
2019English

Prognostic Genes of Triple‑negative Breast Cancer Identified by Weighted Gene Co‑expression Network Analysis

Oncology Letters
Cancer ResearchOncology
2019English

E-Cadherin as a Prognostic Indicator in Primary Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2001English

Prognostic Analysis of Gastric Gastrointestinal Stromal Tumor With Synchronous Gastric Cancer

World Journal of Surgical Oncology
SurgeryOncology
2014English

Prognostic Value of Excision Repair Cross-Complementation Group 1 Expression in Gastric Cancer: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy